Advicenne Prepares its Expansion with Highly Experienced Industry Professionals

September 25, 2018
  • Charlotte Sibley joins the Board of Directors as Independent Member.
  • Paul Michalet is appointed as Chief Financial Officer.

Advicenne (Euronext: ADVIC), a specialty pharmaceutical company focused on the development of pediatric-friendly therapeutics for the treatment of orphan renal and neurological diseases, announced today the appointment of Charlotte Sibley as Independent Director to its Board of Directors and Paul Michalet as Chief Financial Officer…